R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
Back to search
Official data from USPTO
PRECISMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PRECISMED
ST13
US500000088785409Class
42, 44
Filing
88785409
Registration
6615979
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
01/11/2022
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
02/05/2020
Registration date
01/11/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/11/2022
Last transaction
01/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/31/2021
First use in commerce
03/31/2021
Drawing code
4
Owner type
03
Owner location
Plymouth, MI
Examiner
BAYLISS,HUNTER A
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Phenomics Health Inc.
Phenomics Health Inc.
Representatives
Roger H. Bora THOMPSON HINE LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SaaS) services featuring software for use in medical research data collection and managementdatabase managementallowing physicians to share and receive clinical datamonitoring patient datamonitoring patient clinical datamonitoring medications in a patient's circulation to support treatment decisionsanalyzing and recording testinganalysis and evaluation of blood samples for the purpose of improving the identification and quantitative measurement of patient drug exposureimproving the monitoring and diagnosis of patient drug complianceimproving drug dosage recommendationsinitial drug prescribing practicesidentifying drug-drug interactionsdeveloping medical diagnostic products and prescription drugs for the purpose of improving patient outcomes in the field of healthcare; Platform as a Service (PaaS) featuring computer software that allows users to monitor patient datapatient clinical datamedications in a patient's circulation to support treatment decisions; Providing an interactive website featuring technology that allows users to monitor patient datapatient clinical datamedications in a patient's circulation to support treatment decisions; scientific and technological servicesproviding medical and scientific research featuring testinganalysis and evaluation of blood samples for the purpose of improving the identification and quantitative measurement of patient drug exposureimproving the monitoring and diagnosis of patient drug complianceimproving drug dosage recommendationsinitial drug prescribing practicesidentifying drug-drug interactionsdeveloping medical diagnostic products and prescription drugs; scientific and technological services in the nature of testinganalysis and evaluation of blood samples for research purposes and for research in the field of clinical trials
Class 44
Medical testingtestinganalysis and evaluation of blood samples for clinical treatment purposes; Medical testing services in the nature of testinganalysis and evaluation of blood samples for diagnostic and treatment purposes
Publications
History of USPTO decisions and trademark events.
36 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/10/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/10/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2021
GNRT
NON-FINAL ACTION E-MAILED
05/10/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/15/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/14/2021
EX1G
SOU EXTENSION 1 GRANTED
04/14/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/14/2021
IUAF
USE AMENDMENT FILED
04/02/2021
EXT1
SOU EXTENSION 1 FILED
04/02/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/02/2021
EISU
TEAS STATEMENT OF USE RECEIVED
04/02/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2020
PUBO
PUBLISHED FOR OPPOSITION
08/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/22/2020
ALIE
ASSIGNED TO LIE
07/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
06/26/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/26/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
06/26/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/29/2020
GNRT
NON-FINAL ACTION E-MAILED
04/29/2020
CNRT
NON-FINAL ACTION WRITTEN
04/29/2020
DOCK
ASSIGNED TO EXAMINER
04/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2020
NWAP
NEW APPLICATION ENTERED
02/08/2020
Continuous trademark protection
Get notified about every new filing that threatens PRECISMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.